AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Hanford Pharmaceuticals Inc. has recalled four lots of cefazolin for injection due to the possibility of microbial contamination, which may pose a serious or life-threatening risk for some patients.
The recall affects 379,975 vials (1 g/10 mL) in lots distributed by Sandoz Inc. (C4650 and C4537) and Watson Pharmaceuticals Inc. (C4689 and C4665).
Certain lots of the active ingredient used to manufacture the product have been shown to contain microbial contamination, including Bacillus pumilus, Staphylococcus hominis, Propionibacterium acnes, and Micrococcus luteus. ...